DOAC Interferences

DOAC Interferences
Sep 20, 2017 11:50am

Andrew Goodwin, MD, Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, told us about several substance that interfere with direct oral anticoagulant therapy and pointed us to the University of Washington Anticoagulation Services web site. For example, rivaroxaban (Xarelto) is potntiated by P-glycoprotein inhibitors and CYP3A4 inhibitors. Click or tap the link for the full list.


Leave A Comment

You must be logged in to Comment - Sign In